2019 was a year jam packed with brilliant progress and new challenges for cancer research. Here are some of the top stories of the year: Re-writing the breast cancer rulebook, A cancer breath test enters trials, three new teams take on some of the biggest challenges in cancer research, tracking cancer evolution with the TRACERx lung study, See more at: https://scienceblog.cancerresearchuk.org/2019/12/17/cruk-biggest-cancer-news-stories-2019/...
First-in-human trial for new lung cancer immunotherapy
Cancer Research UK and Vaccitech Oncology Limited (VOLT), announced Wednesday that a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine treatment developed by VOLT, a strategic collaboration between Vaccitech Ltd and the Ludwig Institute for Cancer Research, is designed to stimulate the body’s immune system to…...
News digest – prostate cancer MRI trial, drug delivery, cancer ‘cures’ on Facebook and weight loss
New headlines on cancer research: -A prostate cancer MRI trial is in progress -Treatment that delivers drugs straight to tumor given for the first time -WHO approves cheap copy of common breast cancer drug -Facebook bans ads promoting fake cancer “cures” –Post-menopausal women who are overweight could reduce their risk…...
Future Cancer Research Leaders
The US Chinese Anti-Cancer Association and the Asian Fund for Cancer Research jointly awarded five outstanding Chinese cancer researchers in the early stages of their careers with the 2019 USCACA-AFCR Young Investigator Award (also known as the USCACA-AFCR Scholar Award of Clinical, Translational and Basic Cancer Research). The scientists each…...
2019 Give to Cure Cancer Year-End Appeal
The 2019 Give to Cure Cancer Year-End Appeal is now underway. It’s your chance to make this year’s campaign the most successful ever. This past year, we continued to fund several promising cancer research programs. With support from loyal donors like you, excellent progress has been made in these AFCR-funded…...
Late stage breast cancer survival estimate is ‘rarely accurate’
Specialists warn that single number average survival estimates for advanced stage breast cancer are unhelpful and usually inaccurate. Instead, they advise doctors to provide several case-specific survival estimates to help people plan with realism and hope. Breast cancer is the form of cancer that affects women the most often — about 2.1 million women worldwide receive…...
Findings could identify aggressive breast cancers that will respond to immunotherapy
The U.S. Food and Drug Administration recently approved a treatment that combines an immunotherapy drug and chemotherapy for triple negative breast cancer, but not all cases of this aggressive form of breast cancer responded in clinical studies. UNC Lineberger researchers discovered biological clues that could help identify which tumors might…...
Blocking a survival mechanism could tackle melanoma treatment resistance
The effectiveness of current treatments for melanoma, the deadliest form of skin cancer, could be improved by using approaches that wipe out the ‘survival system’ of cancer cells according to a study published in Nature Communications. Researchers from the Babraham Institute, AstraZeneca and the Cancer Research UK Cambridge Centre have demonstrated an approach, used in parallel with existing…...
Liver cancer deaths climb by around 50% in the last decade
Liver cancer death rates have increased by around 50% in the last decade and have tripled since records began, according to the latest calculations by Cancer Research UK. New mortality data shows that there were around 5,700 deaths from liver cancer in 2017 in the UK, which is the highest ever yearly…...
